Search alternatives:
significant data » significant gap (Expand Search), significant anti (Expand Search), significant degs (Expand Search)
larger decrease » marked decrease (Expand Search)
lower decrease » linear decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
Showing 81 - 100 results of 78,799 for search '(( significantly ((lower decrease) OR (larger decrease)) ) OR ( significant data revealed ))', query time: 1.07s Refine Results
  1. 81
    S5 Fig -

    S5 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  2. 82
    Scenario analysis for pembrolizumab using a cumulative cost-based price per year per vial.

    Scenario analysis for pembrolizumab using a cumulative cost-based price per year per vial. by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  3. 83
    S3 Fig -

    S3 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  4. 84
    S6 Fig -

    S6 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  5. 85
    CBP per cumulative indication for daratumumab and pembrolizumab per vial.

    CBP per cumulative indication for daratumumab and pembrolizumab per vial. by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  6. 86
    Inputs utilized in base-case and scenario analysis for daratumumab and pembrolizumab, both unadjusted and adjusted for PPP and inflation.

    Inputs utilized in base-case and scenario analysis for daratumumab and pembrolizumab, both unadjusted and adjusted for PPP and inflation. by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  7. 87
    Implementation of indication-based pricing (10<sup>th</sup> scenario) for daratumumab and pembrolizumab.

    Implementation of indication-based pricing (10<sup>th</sup> scenario) for daratumumab and pembrolizumab. by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  8. 88
    Scenario analysis for daratumumab using a cumulative cost-based price per year per vial.

    Scenario analysis for daratumumab using a cumulative cost-based price per year per vial. by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  9. 89
    Input parameters for the base-case analysis.

    Input parameters for the base-case analysis. by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  10. 90
    S2 Fig -

    S2 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  11. 91
    S1 Data -

    S1 Data - by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  12. 92
    Trend of TI values with age: The TI values decreased significantly with the increase of age, * p<0.01 vs other groups.

    Trend of TI values with age: The TI values decreased significantly with the increase of age, * p<0.01 vs other groups. by Yunmeng Da (707943)

    Published 2024
    Save to List
    Saved in:
  13. 93
    Raw data.

    Raw data. by Yin Jie (21464235)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 94
    Summary table of demographic data at different time points.

    Summary table of demographic data at different time points. by Yannis Karrer (14203825)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  15. 95
    Decreased childhood asthma hospitalizations linked to hotter, drier climate with lower wind speed in drylands

    Decreased childhood asthma hospitalizations linked to hotter, drier climate with lower wind speed in drylands by Klézio Silva Monte (20579829)

    Published 2025
    Save to List
    Saved in:
  16. 96
    The scoring data of the x–rays revealed no significant differences between the groups in terms of degenerative changes.

    The scoring data of the x–rays revealed no significant differences between the groups in terms of degenerative changes. by Markus L. Schwarz (3335586)

    Published 2019
    “…<p>The scoring data of the x–rays revealed no significant differences between the groups in terms of degenerative changes.…”
    Save to List
    Saved in:
  17. 97
    Occurrence of species that increased and decreased across surveys.

    Occurrence of species that increased and decreased across surveys. by Paul H. Zedler (2905520)

    Published 2023
    Save to List
    Saved in:
  18. 98
    Data_Sheet_1_The Two Faces of Tumor-Associated Macrophages and Their Clinical Significance in Colorectal Cancer.pdf

    Data_Sheet_1_The Two Faces of Tumor-Associated Macrophages and Their Clinical Significance in Colorectal Cancer.pdf by Marta L. Pinto (2937843)

    Published 2019
    Save to List
    Saved in:
  19. 99
    Biological significance of genes in DFC revealed by the discriminative ability.

    Biological significance of genes in DFC revealed by the discriminative ability. by Takeru Fujii (11731550)

    Published 2021
    Save to List
    Saved in:
  20. 100
    Potential target protein interaction (PPI) network (Annotation: The smaller circle represents the target, and the larger the circle, the more important the target).

    Potential target protein interaction (PPI) network (Annotation: The smaller circle represents the target, and the larger the circle, the more important the target). by Lin Zhou (141050)

    Published 2023
    Save to List
    Saved in:

Search Tools: